Leustatin



Indications and Reactions:

Role Indications Reactions
Primary
Hairy Cell Leukaemia 11.5%
B-cell Lymphoma 11.3%
Prophylaxis 10.0%
Pyrexia 6.8%
Drug Use For Unknown Indication 6.3%
Infection Prophylaxis 6.0%
Antifungal Prophylaxis 5.8%
Mantle Cell Lymphoma 5.0%
Product Used For Unknown Indication 4.7%
Prophylaxis Against Gastrointestinal Ulcer 4.2%
Tonsillar Inflammation 3.9%
Constipation 3.7%
Extranodal Marginal Zone B-cell Lymphoma (Malt Type) 3.6%
Infection 2.7%
Non-hodgkin's Lymphoma 2.6%
Antibiotic Prophylaxis 2.4%
Chronic Lymphocytic Leukaemia 2.4%
Hypertension 2.4%
Pneumocystis Jiroveci Pneumonia 2.4%
Analgesic Therapy 2.3%
White Blood Cell Count Decreased 31.4%
Thrombocytopenia 13.3%
Pancytopenia 5.7%
Pyrexia 4.8%
Platelet Count Decreased 3.8%
Pneumocystis Jiroveci Pneumonia 3.8%
Respiratory Failure 3.8%
Sepsis 3.8%
White Blood Cell Disorder 3.8%
Monocyte Count Decreased 2.9%
Pharyngolaryngeal Pain 2.9%
Rash 2.9%
Stomatitis 2.9%
Weight Increased 2.9%
Blood Creatinine Increased 1.9%
Cardiac Disorder 1.9%
Glioblastoma 1.9%
Hepatotoxicity 1.9%
Liver Function Test Abnormal 1.9%
Nerve Injury 1.9%
Secondary
Mantle Cell Lymphoma 11.4%
B-cell Lymphoma 11.0%
Prophylaxis 9.9%
Antifungal Prophylaxis 9.0%
Prophylaxis Against Gastrointestinal Ulcer 7.2%
Hairy Cell Leukaemia 6.8%
Atrial Fibrillation 5.6%
Pyrexia 5.6%
Infection Prophylaxis 5.2%
Constipation 4.6%
Hyperuricaemia 3.2%
Prophylaxis Of Nausea And Vomiting 3.1%
Abdominal Pain 2.5%
Constipation Prophylaxis 2.5%
Nasopharyngitis 2.5%
Premedication 2.5%
Myeloproliferative Disorder 2.1%
Drug Use For Unknown Indication 2.0%
Cardiac Failure 1.8%
Anaemia 1.3%
White Blood Cell Count Decreased 43.9%
Thrombocytopenia 11.2%
Pneumonitis Cryptococcal 7.5%
Myeloproliferative Disorder 4.7%
Sepsis 4.7%
White Blood Cell Disorder 4.7%
Neutrophil Count Decreased 2.8%
Stomatitis 2.8%
Weight Increased 2.8%
Leukaemia 1.9%
Pancytopenia 1.9%
Tendon Rupture 1.9%
Troponin Increased 1.9%
White Blood Cell Count Increased 1.9%
Bone Marrow Failure 0.9%
Cytomegalovirus Test Positive 0.9%
Inflammation 0.9%
Pain In Jaw 0.9%
Protein Total Decreased 0.9%
Tonsillitis 0.9%
Concomitant
Non-hodgkin's Lymphoma 15.0%
Prophylaxis 15.0%
Asthma 10.0%
Blood Pressure 10.0%
Chemotherapy 10.0%
Cystitis 10.0%
Angina Pectoris 5.0%
Drug Use For Unknown Indication 5.0%
Fungal Skin Infection 5.0%
Gastrointestinal Fungal Infection 5.0%
Rash Pruritic 5.0%
Restless Legs Syndrome 5.0%
Headache 9.1%
Leukaemic Infiltration Gingiva 9.1%
Lung Neoplasm 9.1%
Lung Neoplasm Malignant 9.1%
Neutropenia 9.1%
Sensory Disturbance 9.1%
Thrombocytopenia 9.1%
Tongue Blistering 9.1%
Tremor 9.1%
Urticaria 9.1%
Weight Decreased 9.1%